72 related articles for article (PubMed ID: 9587932)
1. Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.
Leweke F; Damian MS; Schindler C; Schachenmayr W
Pathol Res Pract; 1998; 194(3):149-55. PubMed ID: 9587932
[TBL] [Abstract][Full Text] [Related]
2. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
[TBL] [Abstract][Full Text] [Related]
3. [Chemosensitivity test on brain tumors].
Gil-Salú JL; Bosco-López J; Domi Nguez-Villar M; Domínguez-Pascual I; Pérez-Requena J; Palomo MJ; López-Escobar M
Neurocirugia (Astur); 2008 Feb; 19(1):5-11. PubMed ID: 18335150
[TBL] [Abstract][Full Text] [Related]
4. Reversal of chemoresistance in malignant gliomas by calcium antagonists: correlation with the expression of multidrug-resistant p-glycoprotein.
Kiwit JC; Hertel A; Matuschek AE
J Neurosurg; 1994 Oct; 81(4):587-94. PubMed ID: 7931593
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
Kang MK; Kang SK
Biochem Biophys Res Commun; 2008 Sep; 373(4):539-44. PubMed ID: 18590702
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas.
Nakagawa T; Ido K; Sakuma T; Takeuchi H; Sato K; Kubota T
Neuropathology; 2009 Aug; 29(4):379-88. PubMed ID: 19019175
[TBL] [Abstract][Full Text] [Related]
7. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
9. Repetitive doxorubicin treatment of glioblastoma enhances the PGP expression--a special role for endothelial cells.
Rittierodt M; Harada K
Exp Toxicol Pathol; 2003 Jul; 55(1):39-44. PubMed ID: 12940627
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy resistance of glioblastoma stem cells.
Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
[No Abstract] [Full Text] [Related]
11. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.
Hazlehurst LA; Foley NE; Gleason-Guzman MC; Hacker MP; Cress AE; Greenberger LW; De Jong MC; Dalton WS
Cancer Res; 1999 Mar; 59(5):1021-8. PubMed ID: 10070958
[TBL] [Abstract][Full Text] [Related]
12. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of ACNU, BCNU, CDDP, and bleomycin on human glioma cells.
Iwata K; Yung WK; Fields WS
Neurol Med Chir (Tokyo); 1988 Oct; 28(10):965-9. PubMed ID: 2462685
[No Abstract] [Full Text] [Related]
15. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
[TBL] [Abstract][Full Text] [Related]
16. Epothilone B induces glioblastoma cell death via survivin down-regulation.
Quick QA
Exp Oncol; 2008 Sep; 30(3):195-201. PubMed ID: 18806741
[TBL] [Abstract][Full Text] [Related]
17. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
[TBL] [Abstract][Full Text] [Related]
18. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
[TBL] [Abstract][Full Text] [Related]
19. [Study on MGMT assay and tumor individual predictable chemotherapy].
Zhang YP
Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy.
von Bossanyi P; Diete S; Dietzmann K; Warich-Kirches M; Kirches E
Acta Neuropathol; 1997 Dec; 94(6):605-11. PubMed ID: 9444363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
